<DOC>
	<DOCNO>NCT02541955</DOCNO>
	<brief_summary>This Rheumatoid Arthritis ( RA ) study . The purpose research study determine RA flare , whether musculoskeletal ultrasound ( MSUS ) inflammatory score and/or disease activity score improve Acthar treatment .</brief_summary>
	<brief_title>Use Acthar Rheumatoid Arthritis ( RA ) Related Flares</brief_title>
	<detailed_description>Participants active RA flair assign take one two Acthar dos , either 40 unit per week 80 unit twice week . Both arm take drug 4 week . Each participant come back visit 2 week , 1 month 3 month initial baseline visit . During visit follow information collect : MSUS joint , DAS28 , Clinical Disease Activity Index ( CDAI ) , Routine Assessment Patient Index Data 3 ( RAPID3 ) Health Assessment Questionnaire-Disability Index ( HAQ-DI ) . Participants also ask fill questionnaire health status . Efficacy Acthar decrease evidence MSUS synovitis disease activity measure analyze use mentioned instrument , well Acthar 's ability prevent necessity change patient ' RA treatment regimen .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>1 . Patient must meet 1987 ACR criterion 2 . Age &gt; 18 year age 3 . Baseline DAS28/Erythrocyte Sedimentation Rate ( ESR ) &gt; =3.2 4 . Stable concomitant Disease Modifying AntiRheumatic Drugs ( DMARDs ) 5 . Stable prednisone &lt; 10mg equivalent 6 . Power Doppler score &gt; =10 1 . Prior treatment Acthar 2 . Meet one RA flare requirement 3 . Subjects receive live live attenuate vaccine within 6 week prior first dose study drug ( zoster vaccine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Rheumatoid arthritis ( RA )</keyword>
	<keyword>Musculoskeletal ultrasound ( MSUS )</keyword>
</DOC>